SKTO.US Sk3 Group Inc
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- 196.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2013.
Is SKTO.US undervalued?
Graham numberThe Graham number of Sk3 Group Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sk3 Group Inc fundamental analysis
No fundamental analysis for Sk3 Group Inc yet.
Sk3 Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sk3 Group Inc
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in the…
Full company profileSk3 Group Inc financial statements
2013 annualized: Fiscal year 2013 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2013, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sk3 Group Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0.00 | 15.4K | 5.56M | 7.95M | 0.00 | 0.00 | 36.2M |
| Gross Profit | 0.00 | 15.4K | 4.32M | 5.72M | 0.00 | 0.00 | 36.2M |
| Operating Income | -90.3K | -80.9K | 248K | 82.9K | -74.4K | -450K | 35.5M |
| Net Income | -112K | -82.5K | 246K | 22.2K | -74.6K | -450K | 35.5M |
| Balance Sheet | |||||||
| Total Assets | 261.00 | 991.00 | 947K | 1.34M | - | - | 19.0M |
| Total Liabilities | 196K | 278K | 979K | 1.34M | 153K | 603K | 894K |
| Shareholders' Equity | -196K | -277K | -31.8K | 1.37K | - | - | 18.1M |
| Cash & Short-term Investments | - | 191.00 | 292K | 520K | - | - | - |
| Cash Flow | |||||||
| Operating Cash Flow | -7.74K | 254K | 254K | -33.9K | -45.1K | -594K | -166K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.09M |
| Ratios | |||||||
| ROE | - | - | - | 1,617.0% | - | - | 196.4% |
| ROA | -42,996.6% | -8,322.6% | 26.0% | 1.7% | - | - | 187.1% |
| Net Profit Margin | - | -536.3% | 4.4% | 0.3% | - | - | 97.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Sk3 Group Inc dividends
Sk3 Group Inc has not paid dividends in the last 6 fiscal years.
Last stock split: 3:1 on May 18, 2007.
Who owns Sk3 Group Inc
Ownership data of Sk3 Group Inc is not available yet.
Sk3 Group Inc company profile
- Company name
- Sk3 Group Inc
- Ticker
- SKTO.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 15
- Fiscal year end
- December
- Address
- 448 South Hill Street, Los Angeles, CA, United States, 90013
- Phone
- 305-423-7144
- Website
- -
About Sk3 Group Inc
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. The company was formerly known as CTT International Distributors, Inc. and changed its name to SK3 Group, Inc. in May 2007. The company was founded in 2000 and is headquartered in Los Angeles, California. SK3 Group, Inc. is a subsidiary of Healthcare of Today, Inc.
Sk3 Group Inc management
1- Mr. Artemus MayorChief Executive Officer and President · born 1968